144 related articles for article (PubMed ID: 9003069)
1. Acetylcholine release in the rat prefrontal cortex in vivo: modulation by alpha 2-adrenoceptor agonists and antagonists.
Tellez S; Colpaert F; Marien M
J Neurochem; 1997 Feb; 68(2):778-85. PubMed ID: 9003069
[TBL] [Abstract][Full Text] [Related]
2. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo.
Tellez S; Colpaert F; Marien M
Neuroscience; 1999; 89(4):1041-50. PubMed ID: 10362293
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonist.
Halliday CA; Jones BJ; Skingle M; Walsh DM; Wise H; Tyers MB
Br J Pharmacol; 1991 Apr; 102(4):887-95. PubMed ID: 1677298
[TBL] [Abstract][Full Text] [Related]
4. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
5. The alpha 2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo.
Tellez S; Colpaert F; Marien M
Eur J Pharmacol; 1995 Apr; 277(1):113-6. PubMed ID: 7635166
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies.
Dalley JW; Stanford SC
Br J Pharmacol; 1995 Apr; 114(8):1717-23. PubMed ID: 7599940
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Chopin P; Colpaert FC; Marien M
J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
[TBL] [Abstract][Full Text] [Related]
9. Prejunctional alpha 2-adrenoceptors inhibit acetylcholine release from cholinergic nerves in equine airways.
Yu M; Wang Z; Robinson NE
Am J Physiol; 1993 Dec; 265(6 Pt 1):L565-70. PubMed ID: 7904128
[TBL] [Abstract][Full Text] [Related]
10. Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.
Jentsch JD; Sanchez D; Elsworth JD; Roth RH
Brain Res; 2008 Dec; 1246():41-6. PubMed ID: 18977208
[TBL] [Abstract][Full Text] [Related]
11. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
12. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
Gobert A; Di Cara B; Cistarelli L; Millan MJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
[TBL] [Abstract][Full Text] [Related]
13. Determination of the somatodendritic alpha2-adrenoceptor subtype located in rat locus coeruleus that modulates cortical noradrenaline release in vivo.
Mateo Y; Meana JJ
Eur J Pharmacol; 1999 Aug; 379(1):53-7. PubMed ID: 10499371
[TBL] [Abstract][Full Text] [Related]
14. Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct alpha 2-adrenoceptor sites.
Intengan HD; Smyth DD
Br J Pharmacol; 1996 Oct; 119(4):663-70. PubMed ID: 8904639
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2A-adrenoceptor-specific stimulation of [35S]GTP gamma S binding to membrane preparations of rat frontal cortex.
Pulges O; Rinken A
Neurochem Res; 2008 Mar; 33(3):477-82. PubMed ID: 17786553
[TBL] [Abstract][Full Text] [Related]
16. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
Haapalinna A; Leino T; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ
Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
19. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
Roach AG; Doxey JC; Strachan DA; Cavero I
J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427
[TBL] [Abstract][Full Text] [Related]
20. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
Berridge TL; Doxey JC; Roach AG; Smith CF
Eur J Pharmacol; 1992 Mar; 213(2):205-12. PubMed ID: 1355733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
